Skin sensitization occurs when a skin sensitizer binds covalently to skin proteins through the haptenation process. The objective of this study was to correlate the electrochemical impedance spectroscopy (EIS) data of a screen printed carbon electrode (SPCE) modified with cysteine and gold nanoparticles (AuNPs) with local lymph node assay (LLNA) data as a potential skin sensitizer biosensor. The EIS was used to quantify variations in charge transfer resistance of skin sensitizers (ΔR) due to different binding rates of skin sensitizers to cysteine. SPCE was modified through electrodeposition of AuNPs/thiourea/self-assembly of AuNPs/cysteine (assigned as ETSC) for the detection of skin sensitizers. Surface analysis of modified SPCEs using FESEM and EDX revealed a smooth surface with an uneven distribution of cysteine with AuNPs molecules. The ETSC modified SPCE showed a significant skin sensitizer biosensor since the ΔR readings were increased proportionally to the strength of the skin sensitizers, with strong/extreme skin sensitizers displaying higher ΔR readings compared to moderate and weak/non-skin sensitizers. The skin sensitization analysis from this work was compared to LLNA (animal study), human cell line activation (h-CLAT), direct peptide reactivity assay (DPRA), and KeratinoSens™, surface plasmon resonance (SPR) matched the categorization of LLNA in the following descending order: 96%, 92%, 82%, 70%, 70%, and 12%. With just an 8% mismatch with LLNA data, the EIS approach used in this study could be used as a screening tool for skin sensitizers.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.tiv.2022.105433 | DOI Listing |
Potency and quantitative risk assessment are essential for determining safe concentrations for the formulation of potential skin sensitizers into consumer products. Several new approach methodologies (NAMs) for skin sensitization hazard assessment have been developed, validated, and adopted in OECD test guidelines. However, work is ongoing to develop NAMs for predicting skin sensitization potency on a quantitative scale for use as a point of departure (POD) in next-generation risk assessment (NGRA).
View Article and Find Full Text PDFCurr Opin Allergy Clin Immunol
January 2025
Department of Pulmonology, Allergy and Thoracic Oncology, University Hospital of Montpellier, Montpellier, France.
Purpose Of Review: Climate change influences working conditions in various ways, affecting employee health and safety across different sectors. Climatic factors like rising temperatures, increased UV radiation, and more frequent extreme weather events pose risks to in both indoor and outdoor workers. Allergic diseases of the respiratory tract and the skin may emerge due to climate change.
View Article and Find Full Text PDFXenotransplantation
January 2025
Department of Surgery, Duke University School of Medicine, Durham, North Carolina, USA.
Background: The removal of preformed antibodies with cleaving enzyme like IdeS (Imlifidase) has demonstrated therapeutic potential in organ transplantation for sensitized recipients. However, preformed xenoreactive antibodies (XAbs) against porcine glycans are predominantly IgM and considered detrimental in pig-to-human xenotransplantation.
Methods: Recombinant IceM, an endopeptidase cleaving IgM, was generated in Escherichia coli.
Background: Identification of young children with ( )-infection is critical to curb Tuberculosis (TB)-related pediatric morbidity and mortality. The optimal test to identify young children with evidence of -infection remains controversial.
Methods: Using a TB household contact (HHC) study design among 130 Ugandan children less than 5 years with established -exposure, we compared the usefulness of the tuberculin skin test (TST) and QuantiFERON Gold Plus (QFT-Plus) to identify children with evidence for -sensitization.
Following a request from the European Commission, EFSA was asked to deliver a scientific opinion on the assessment of the application for renewal of the authorisation of a preparation of NCIMB 30005 as technological additive to improve ensiling of fresh material for all animal species. The applicant has provided evidence that the additive currently on the market complies with the existing conditions of authorisation. There was no new evidence that would lead the EFSA Panel on Additives and Products or Substances used in Animal Feed (FEEDAP) to reconsider its previous conclusions for all animal species, consumers and the environment, for which the additive is considered to remain safe.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!